Mike Polark
Stock Analyst at Baird
(2.11)
# 2,822
Out of 5,182 analysts
88
Total ratings
40.35%
Success rate
-3.05%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Neutral | $63 → $50 | $47.15 | +6.04% | 12 | May 5, 2026 | |
| IRTC iRhythm Holdings | Maintains: Outperform | $220 → $200 | $127.35 | +57.05% | 14 | Feb 20, 2026 | |
| MDLN Medline | Initiates: Outperform | $47 | $41.29 | +13.83% | 1 | Jan 12, 2026 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $84.21 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $78.98 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $10.81 | +85.01% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $69.80 | -14.03% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $160.86 | +117.58% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $21.51 | +34.82% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $208.86 | -13.82% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $83.79 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $298.22 | +35.81% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $461.06 | +9.10% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $87.88 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $135.93 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $61.41 | +97.04% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $18.36 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $16.15 | +54.85% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $178.63 | -7.63% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $57.86 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $19.00 | -31.58% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $3.20 | +556.25% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $215.52 | +16.00% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $0.92 | +4,573.91% | 1 | Sep 2, 2020 |
Inspire Medical Systems
May 5, 2026
Maintains: Neutral
Price Target: $63 → $50
Current: $47.15
Upside: +6.04%
iRhythm Holdings
Feb 20, 2026
Maintains: Outperform
Price Target: $220 → $200
Current: $127.35
Upside: +57.05%
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $41.29
Upside: +13.83%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $84.21
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $78.98
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $10.81
Upside: +85.01%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $69.80
Upside: -14.03%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $160.86
Upside: +117.58%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $21.51
Upside: +34.82%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $208.86
Upside: -13.82%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $83.79
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $298.22
Upside: +35.81%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $461.06
Upside: +9.10%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $87.88
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $135.93
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $61.41
Upside: +97.04%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $18.36
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $16.15
Upside: +54.85%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $178.63
Upside: -7.63%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $57.86
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $19.00
Upside: -31.58%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $3.20
Upside: +556.25%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $215.52
Upside: +16.00%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $0.92
Upside: +4,573.91%